Paradigm Capital Management Inc. NY Invests $1.42 Million in Cross Country Healthcare, Inc. $CCRN

Paradigm Capital Management Inc. NY purchased a new position in Cross Country Healthcare, Inc. (NASDAQ:CCRN) during the 2nd quarter, Holdings Channel reports. The fund purchased 107,700 shares of the business services provider’s stock, valued at approximately $1,423,000.

Other large investors have also recently made changes to their positions in the company. BlackRock Inc. purchased a new position in Cross Country Healthcare during the second quarter valued at approximately $36,329,000. Quinn Opportunity Partners LLC bought a new position in Cross Country Healthcare during the fourth quarter valued at approximately $8,470,000. Boston Partners bought a new position in shares of Cross Country Healthcare during the 4th quarter valued at approximately $6,414,000. Dana Investment Advisors Inc. grew its stake in shares of Cross Country Healthcare by 71.2% in the 4th quarter. Dana Investment Advisors Inc. now owns 1,008,525 shares of the business services provider’s stock worth $8,169,000 after buying an additional 419,429 shares in the last quarter. Finally, Goldman Sachs Group Inc. grew its position in Cross Country Healthcare by 56.9% in the first quarter. Goldman Sachs Group Inc. now owns 1,095,178 shares of the business services provider’s stock worth $16,307,000 after acquiring an additional 397,216 shares in the last quarter. 96.03% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research analysts have commented on CCRN shares. Truist Financial lifted their price objective on shares of Cross Country Healthcare from $10.00 to $13.25 and gave the stock a “hold” rating in a research note on Monday, May 11th. Weiss Ratings upgraded Cross Country Healthcare from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday, July 16th. Citizens Jmp downgraded shares of Cross Country Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Thursday, May 7th. Barrington Research reissued a “market perform” rating and issued a $13.25 price target on shares of Cross Country Healthcare in a research report on Monday, June 8th. Finally, Wedbush lowered shares of Cross Country Healthcare from an “outperform” rating to a “hold” rating and reduced their price objective for the stock from $15.00 to $13.25 in a research note on Thursday, May 7th. Nine research analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Reduce” and a consensus target price of $12.05.

Cross Country Healthcare Stock Performance

Shares of NASDAQ CCRN opened at $13.25 on Tuesday. Cross Country Healthcare, Inc. has a 12 month low of $7.43 and a 12 month high of $14.99. The stock has a market cap of $428.05 million, a price-to-earnings ratio of -4.34, a PEG ratio of 14.32 and a beta of 0.45. The company has a 50 day simple moving average of $13.23 and a two-hundred day simple moving average of $11.45.

Cross Country Healthcare Profile

Cross Country Healthcare, Inc, headquartered in Boca Raton, Florida, is a leading provider of healthcare workforce solutions in the United States. The company specializes in the recruitment, placement and management of nursing and allied health professionals on both a travel and permanent basis. Through its integrated platform, Cross Country Healthcare serves hospitals, health systems, and long-term care facilities by matching qualified clinical talent with patient care needs across diverse care settings.

The company’s core service offerings include travel nurse and allied health staffing, per diem staffing, permanent placement services, and managed services programs.